{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T07:30:21Z","timestamp":1765438221409,"version":"3.37.3"},"reference-count":53,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T00:00:00Z","timestamp":1576195200000},"content-version":"vor","delay-in-days":3178,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"crossref","award":["LSHM-CT-2005-018637"],"award-info":[{"award-number":["LSHM-CT-2005-018637"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.ajpath.2011.01.003","type":"journal-article","created":{"date-parts":[[2011,2,27]],"date-time":"2011-02-27T13:44:52Z","timestamp":1298814292000},"page":"1770-1781","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Anti-Inflammatory Effects of FTY720 Do Not Prevent Neuronal Cell Loss in a Rat Model of Optic Neuritis"],"prefix":"10.1016","volume":"178","author":[{"given":"Christian R.","family":"Rau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharina","family":"Hein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muriel B.","family":"S\u00e4ttler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benedikt","family":"Kretzschmar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carina","family":"Hillgruber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradford L.","family":"McRae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricarda","family":"Diem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathias","family":"B\u00e4hr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2011.01.003_bib1","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1056\/NEJM199801293380502","article-title":"Axonal transection in the lesions of multiple sclerosis","volume":"338","author":"Trapp","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpath.2011.01.003_bib2","doi-asserted-by":"crossref","first-page":"6214","DOI":"10.1523\/JNEUROSCI.21-16-06214.2001","article-title":"Acute neuronal apoptosis in a rat model of multiple sclerosis","volume":"21","author":"Meyer","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.ajpath.2011.01.003_bib3","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0002-9440(10)64537-3","article-title":"Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions","volume":"157","author":"Kornek","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2011.01.003_bib4","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1056\/NEJMoa011341","article-title":"A longitudinal study of abnormalities on MRI and disability from multiple sclerosis","volume":"346","author":"Brex","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpath.2011.01.003_bib5","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1056\/NEJMoa0907839","article-title":"Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis","volume":"362","author":"Cohen","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpath.2011.01.003_bib6","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1056\/NEJMoa0909494","article-title":"A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis","volume":"362","author":"Kappos","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpath.2011.01.003_bib7","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jneuroim.2004.04.015","article-title":"Sphingosine 1-phosphate receptor agonists attenuate relapsing-remitting experimental autoimmune encephalitis in SJL mice","volume":"153","author":"Webb","year":"2004","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.ajpath.2011.01.003_bib8","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1124\/jpet.102.045658","article-title":"Amelioration of experimental autoimmune encephalomyelitis in Lewis rats by FTY720 treatment","volume":"305","author":"Fujino","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.ajpath.2011.01.003_bib9","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1750-3639.2008.00182.x","article-title":"FTY720 rescue therapy in the dark agouti rat model of experimental autoimmune encephalomyelitis: expression of central nervous system genes and reversal of blood-brain-barrier damage","volume":"19","author":"Foster","year":"2009","journal-title":"Brain Pathol"},{"key":"10.1016\/j.ajpath.2011.01.003_bib10","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.neuropharm.2006.11.010","article-title":"Phosphorylated FTY720 stimulates ERK phosphorylation in astrocytes via S1P receptors","volume":"52","author":"Osinde","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ajpath.2011.01.003_bib11","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1517\/13543784.16.3.283","article-title":"FTY720, an immunomodulatory sphingolipid mimetic: translation of a novel mechanism into clinical benefit in multiple sclerosis","volume":"16","author":"Baumruker","year":"2007","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.ajpath.2011.01.003_bib12","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.brainresbull.2007.06.023","article-title":"FTY720 sustains and restores neuronal function in the DA rat model of MOG-induced experimental autoimmune encephalomyelitis","volume":"74","author":"Balatoni","year":"2007","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.ajpath.2011.01.003_bib13","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/glia.1111","article-title":"T- and B-cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis","volume":"36","author":"Iglesias","year":"2001","journal-title":"Glia"},{"key":"10.1016\/j.ajpath.2011.01.003_bib14","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1093\/brain\/awl075","article-title":"Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research","volume":"129","author":"Gold","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.ajpath.2011.01.003_bib15","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/j.1750-3639.1998.tb00194.x","article-title":"Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology","volume":"8","author":"Storch","year":"1998","journal-title":"Brain Pathol"},{"key":"10.1016\/j.ajpath.2011.01.003_bib16","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1750-3639.2004.tb00047.x","article-title":"Mechanisms and time course of neuronal degeneration in experimental autoimmune encephalomyelitis","volume":"14","author":"Hobom","year":"2004","journal-title":"Brain Pathol"},{"key":"10.1016\/j.ajpath.2011.01.003_bib17","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.2353\/ajpath.2006.060159","article-title":"Effects of glatiramer acetate and interferon-beta on neurodegeneration in a model of multiple sclerosis: a comparative study","volume":"169","author":"Maier","year":"2006","journal-title":"Am J Pathol"},{"issue":"Suppl 2","key":"10.1016\/j.ajpath.2011.01.003_bib18","doi-asserted-by":"crossref","first-page":"S181","DOI":"10.1038\/sj.cdd.4401504","article-title":"Neuroprotective effects and intracellular signaling pathways of erythropoietin in a rat model of multiple sclerosis","volume":"11","author":"S\u00e4ttler","year":"2004","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.ajpath.2011.01.003_bib19","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/0042-6989(83)90146-3","article-title":"Aspheric curvatures, refractive indices and chromatic aberration for the rat eye","volume":"23","author":"Chaudhuri","year":"1983","journal-title":"Vision Res"},{"key":"10.1016\/j.ajpath.2011.01.003_sbreference533","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0952-7915(02)00374-6","article-title":"FTY720: targeting G-protein-coupled receptors for sphingosine 1-phosphate in transplantation and autoimmunity","volume":"14","author":"Brinkmann","year":"2002","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.ajpath.2011.01.003_sbreference534","doi-asserted-by":"crossref","first-page":"21453","DOI":"10.1074\/jbc.C200176200","article-title":"The immune modulator FTY720 targets sphingosine 1-phosphate receptors","volume":"277","author":"Brinkmann","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2011.01.003_bib21","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1182\/blood-2005-07-2628","article-title":"Sphingosine kinase type 2 is essential for lymphopenia induced by the immunomodulatory drug FTY720","volume":"107","author":"Zemann","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2011.01.003_bib22","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.expneurol.2006.04.015","article-title":"Effects of interferon-beta-1a on neuronal survival under autoimmune inflammatory conditions","volume":"201","author":"S\u00e4ttler","year":"2006","journal-title":"Exp Neurol"},{"key":"10.1016\/j.ajpath.2011.01.003_bib23","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/j.1600-6143.2004.00476.x","article-title":"FTY720: sphingosine 1-phosphate receptor-1 in the control of lymphocyte egress and endothelial barrier function","volume":"4","author":"Brinkmann","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ajpath.2011.01.003_bib24","first-page":"490","article-title":"The ERG in response to alternating gratings in patients with diseases of the peripheral visual pathway","volume":"21","author":"Fiorentini","year":"1981","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajpath.2011.01.003_bib25","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S1474-4422(02)00102-3","article-title":"The role of nitric oxide in multiple sclerosis","volume":"1","author":"Smith","year":"2002","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ajpath.2011.01.003_bib26","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1750-3639.1999.tb00212.x","article-title":"Demyelination: the role of reactive oxygen and nitrogen species","volume":"9","author":"Smith","year":"1999","journal-title":"Brain Pathol"},{"key":"10.1016\/j.ajpath.2011.01.003_bib27","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/brain\/awh365","article-title":"Combined therapy with methylprednisolone and erythropoietin in a model of multiple sclerosis","volume":"128","author":"Diem","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.ajpath.2011.01.003_bib28","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1007\/s00115-007-2298-9","article-title":"FTY720 (Fingolimod) als neue Therapiem\u00f6glichkeit der Multiplen Sklerose [FTY720 (Fingolimod) as a new therapeutic option for multiple sclerosis]","volume":"78","author":"Klatt","year":"2007","journal-title":"German. Nervenarzt"},{"key":"10.1016\/j.ajpath.2011.01.003_bib29","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2174\/138945007779315669","article-title":"Effects of LPA and S1P on the nervous system and implications for their involvement in disease","volume":"8","author":"Herr","year":"2007","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.ajpath.2011.01.003_bib30","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1750-3639.2004.tb00081.x","article-title":"Ciliary neurotrophic factor protects retinal ganglion cells from secondary cell death during acute autoimmune optic neuritis in rats","volume":"14","author":"Maier","year":"2004","journal-title":"Brain Pathol"},{"key":"10.1016\/j.ajpath.2011.01.003_bib31","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jneuroim.2007.10.021","article-title":"Strain-specific susceptibility for neurodegeneration in a rat model of autoimmune optic neuritis","volume":"193","author":"S\u00e4ttler","year":"2008","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.ajpath.2011.01.003_bib32","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1523\/JNEUROSCI.21-06-02058.2001","article-title":"Reduction of potassium currents and phosphatidylinositol 3-kinase-dependent AKT phosphorylation by tumor necrosis factor-(alpha) rescues axotomized retinal ganglion cells from retrograde cell death in vivo","volume":"21","author":"Diem","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.ajpath.2011.01.003_bib33","doi-asserted-by":"crossref","first-page":"6993","DOI":"10.1523\/JNEUROSCI.23-18-06993.2003","article-title":"Methylprednisolone increases neuronal apoptosis during autoimmune CNS inflammation by inhibition of an endogenous neuroprotective pathway","volume":"23","author":"Diem","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.ajpath.2011.01.003_bib34","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/ni1534","article-title":"The sphingosine 1-phosphate receptor 1 causes tissue retention by inhibiting the entry of peripheral tissue T lymphocytes into afferent lymphatics","volume":"9","author":"Ledgerwood","year":"2008","journal-title":"Nat Immunol"},{"key":"10.1016\/j.ajpath.2011.01.003_bib35","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.2353\/ajpath.2008.080491","article-title":"Flupirtine as neuroprotective add-on therapy in autoimmune optic neuritis","volume":"173","author":"S\u00e4ttler","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2011.01.003_bib36","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1212\/01.wnl.0000338569.32367.3d","article-title":"Oral fingolimod (FTY720) in multiple sclerosis: two-year results of a phase II extension study","volume":"72","author":"O'Connor","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.ajpath.2011.01.003_bib37","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1056\/NEJMoa052643","article-title":"Oral fingolimod (FTY720) for relapsing multiple sclerosis","volume":"355","author":"Kappos","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpath.2011.01.003_bib38","first-page":"439","article-title":"FTY720, sphingosine 1-phosphate receptor modulator, ameliorates experimental autoimmune encephalomyelitis by inhibition of T cell infiltration","volume":"2","author":"Kataoka","year":"2005","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.ajpath.2011.01.003_bib39","first-page":"180","article-title":"Current trends in multiple sclerosis research: an update on pathogenic concepts","volume":"106","author":"Vanderlocht","year":"2006","journal-title":"Acta Neurol Belg"},{"key":"10.1016\/j.ajpath.2011.01.003_bib40","doi-asserted-by":"crossref","first-page":"5283","DOI":"10.1523\/JNEUROSCI.20-14-05283.2000","article-title":"Neuroprotection by encephalomyelitis: rescue of mechanically injured neurons and neurotrophin production by CNS-infiltrating T and natural killer cells","volume":"20","author":"Hammarberg","year":"2000","journal-title":"J Neurosci"},{"key":"10.1016\/j.ajpath.2011.01.003_bib41","doi-asserted-by":"crossref","first-page":"5149","DOI":"10.1523\/JNEUROSCI.23-12-05149.2003","article-title":"Endogenously produced neurotrophins regulate survival and differentiation of cortical progenitors via distinct signaling pathways","volume":"23","author":"Barnab\u00e9-Heider","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.ajpath.2011.01.003_bib42","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.nbd.2006.10.022","article-title":"Multiple neuroprotective mechanisms of minocycline in autoimmune CNS inflammation","volume":"25","author":"Maier","year":"2007","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.ajpath.2011.01.003_bib43","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/jnr.22196","article-title":"FTY720 ameliorates MOG-induced experimental autoimmune encephalomyelitis by suppressing both cellular and humoral immune responses","volume":"88","author":"Papadopoulos","year":"2010","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.ajpath.2011.01.003_bib44","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0006-8993(02)03806-4","article-title":"The role of cytokines and adhesion molecules in axon degeneration after peripheral nerve axotomy: a study in different knockout mice","volume":"960","author":"Siebert","year":"2003","journal-title":"Brain Res"},{"key":"10.1016\/j.ajpath.2011.01.003_bib45","doi-asserted-by":"crossref","first-page":"12467","DOI":"10.1074\/jbc.M610863200","article-title":"Glutaredoxin regulates nuclear factor kappa-B and intercellular adhesion molecule in Muller cells: model of diabetic retinopathy","volume":"282","author":"Shelton","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2011.01.003_bib46","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1212\/WNL.44.9.1747","article-title":"Anti-ICAM-1 antibody reduces ischemic cell damage after transient middle cerebral artery occlusion in the rat","volume":"44","author":"Zhang","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.ajpath.2011.01.003_bib47","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1212\/WNL.45.4.815","article-title":"Monoclonal antibodies preventing leukocyte activation reduce experimental neurologic injury and enhance efficacy of thrombolytic therapy","volume":"45","author":"Bowes","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.ajpath.2011.01.003_bib48","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/ana.21227","article-title":"FTY720 modulates human oligodendrocyte progenitor process extension and survival","volume":"63","author":"Miron","year":"2008","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ajpath.2011.01.003_bib49","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1124\/jpet.107.123927","article-title":"The immunomodulator FTY720 has a direct cytoprotective effect in oligodendrocyte progenitors","volume":"323","author":"Coelho","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.ajpath.2011.01.003_bib50","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1007\/s00115-006-2220-x","volume":"77","author":"Rieckmann","year":"2006","journal-title":"Nervenarzt"},{"key":"10.1016\/j.ajpath.2011.01.003_bib51","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1093\/brain\/awl370","article-title":"Autologous haematopoietic stem cell transplantation fails to stop demyelination and neurodegeneration in multiple sclerosis","volume":"130","author":"Metz","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.ajpath.2011.01.003_bib52","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s00415-005-0934-5","article-title":"The window of therapeutic opportunity in multiple sclerosis: evidence from monoclonal antibody therapy","volume":"253","author":"Coles","year":"2006","journal-title":"J Neurol"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944011000137?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944011000137?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T02:29:38Z","timestamp":1721442578000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944011000137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S0002944011000137"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2011.01.003","relation":{},"ISSN":["0002-9440"],"issn-type":[{"type":"print","value":"0002-9440"}],"subject":[],"published":{"date-parts":[[2011,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-Inflammatory Effects of FTY720 Do Not Prevent Neuronal Cell Loss in a Rat Model of Optic Neuritis","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2011.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 American Society for Investigative Pathology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}